Veronica Hackethal MD

October 09, 2020

Diabetes is a primary risk factor for atherosclerotic cardiovascular disease. Find out how well you know the guideline recommendations for reducing that risk with the first of 4 quizzes.

July 02, 2020

SGLT2 inhibitors and GLP-1 receptor agonists are changing the type 2 diabetes treatment paradigm. We summarize the most recent data here and offer guidance on patient benefits.

November 17, 2017

Migraine-especially with aura-is a CV risk factor, which makes treatment with ergots or triptans potentially problematic. The best approach?